Overview

Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to compare the efficacy and safety of Valsartan/Amlodipine (EXforge®) with nifedipine, as well as vascular function index.

Phase:

Phase 4

Details

Lead Sponsor:

Novartis

Treatments:

Amlodipine
Amlodipine, Valsartan Drug Combination
Antihypertensive Agents
Nifedipine
Valsartan